<Disease><Name>HYPER-IgD SYNDROME</Name><Synonym>PERIODIC FEVER, DUTCH TYPE; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; HIDS</Synonym><OMIM><Number>260920</Number><URL>http://omim.org/entry/260920</URL></OMIM><Orphanet><Number>343</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=343</URL></Orphanet><Protein><Number>mevalonate kinase</Number><URL>http://www.uniprot.org/uniprot/Q03426</URL></Protein><ExPASy><Number>2.7.1.36</Number><URL>http://enzyme.expasy.org/EC/2.7.1.36</URL></ExPASy><Gene>12q24.11</Gene><ICD>E85.0</ICD><Summary>rare (180 cases) ;autosomal recessive;periodic fever syndromes (autoinflammatory disorders): - familial Mediterranean fever (FMF) - hyperimmunoglobulinemia D periodic fever syndrome (HIDS) - tumor necrosis factor receptor-associated periodic syndrome (TRAPS) - PFAPA syndrome (increased procalcitonin) - systemic juvenile idiopathic arthritis (sJIA), non-hereditary</Summary><Symptoms><symtomp><id>3366</id><symptom>amyloidosis</symptom><category>ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES</category></symtomp><symtomp><id>2383</id><symptom>arthralgia</symptom><category>GENERAL TOPICS | SKELETAL DEFECT</category></symtomp><symtomp><id>2129</id><symptom>arthritis</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1713</id><symptom>fever, severe or recurrent</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1925</id><symptom>headache (severe, recurrent or occipital, migraine)</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>2349</id><symptom>night blindness / nyctalopia</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1975</id><symptom>pain, abdominal / pain abdominal</symptom><category>BODY | GENERAL TOPICS</category></symtomp><symtomp><id>2007</id><symptom>recurrent or intermittent skin defect</symptom><category>SKIN</category></symtomp><symtomp><id>1731</id><symptom>retinitis pigmentosa</symptom><category>EYES</category></symtomp><symtomp><id>3343</id><symptom>skin rash, eczematous or seborrhoic / skin rash</symptom><category>SKIN</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2099</id><name>Cysteinyl leukotrienes (LTC4)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>181</id><name>Cysteinyl leukotrienes (LTE4)</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>182</id><name>Cysteinyl leukotrienes (LTE4)</name><specimen>urine</specimen><value>increased</value><min>15.80</min><max>45.20</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>1014</id><name>Immunglobulin IgD</name><specimen>serum</specimen><value>normal/inc</value><min>0.00</min><max>0.00</max><unit>mg/dl</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>692</id><name>Mevalonate kinase</name><specimen>fibroblasts</specimen><value>decreased</value><min>980.00</min><max>1950.00</max><unit>pmol/(min * mg protein)</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1544</id><name>Mevalonic acid</name><specimen>urine</specimen><value>increased</value><min>0.06</min><max>0.21</max><unit>mmol/mol creatinine</unit><age>all</age><method /><comment /></metabolite><metabolite><id>112</id><name>Mevalonic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>689</id><name>Mevalonic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4624</id><title>Autoinflammatory Diseases with Periodic Fevers</title><author>Sag E,</author><journal>Curr Rheumatol Rep</journal><year>2017</year><book /><volume>19</volume><number>7</number><pages>41</pages><co_aut>Bilginer Y, Ozen S</co_aut></literature><literature><id>4625</id><title>The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome</title><author>van der Meer JW,</author><journal>Rheumatology (Oxford)</journal><year>2016</year><book /><volume>55</volume><number>0</number><pages>ii23-29</pages><co_aut>Simon A</co_aut></literature><literature><id>4627</id><title>Mevalonate kinase deficiency: current perspectives</title><author>Favier LA,</author><journal>Appl Clin Genet</journal><year>2016</year><book /><volume>9</volume><number>0</number><pages>101-110</pages><co_aut>Schulert GS</co_aut></literature><literature><id>4626</id><title>Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?</title><author>Mulders-Manders CM,</author><journal>Semin Immunopathol</journal><year>2015</year><book /><volume>37</volume><number>4</number><pages>371-376</pages><co_aut>Simon A</co_aut></literature><literature><id>4629</id><title>Mevalonate kinase deficiency (hyper IgD syndrome with periodic fever)--different faces with separate treatments: two cases and </title><author>Gencp&#305;nar P,</author><journal>Turk J Pediatr</journal><year>2012</year><book /><volume>54</volume><number>6</number><pages>641-644</pages><co_aut>et al.</co_aut></literature><literature><id>2280</id><title>Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency</title><author>Mandey SH</author><journal>Hum Mutat</journal><year>2006</year><book /><volume>27</volume><number>8</number><pages>796-802</pages><co_aut>et al.</co_aut></literature><literature><id>2695</id><title>Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis</title><author>Cailliez M</author><journal>J Inherit Metab Dis</journal><year>2006</year><book /><volume>29</volume><number>6</number><pages>763</pages><co_aut>et al.</co_aut></literature><literature><id>2696</id><title>A patient with hyper-IgD syndrome responding to anti-TNF treatment</title><author>Demirkaya E</author><journal>Clin Rheumatol</journal><year>2006</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2697</id><title>Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome</title><author>Rigante D</author><journal>Rheumatol Int</journal><year>2006</year><book /><volume>27</volume><number>1</number><pages>97-100</pages><co_aut>et al.</co_aut></literature><literature><id>2698</id><title>Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome</title><author>Haas D</author><journal>Orphanet J Rare Dis</journal><year>2006</year><book /><volume>1</volume><number>0</number><pages>13</pages><co_aut>Hoffmann GF</co_aut></literature><literature><id>2279</id><title>MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever</title><author>DOsualdo A</author><journal>Eur J Hum Genet</journal><year>2005</year><book /><volume>13</volume><number>3</number><pages>314-320</pages><co_aut>et al.</co_aut></literature><literature><id>1812</id><title>First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome</title><author>Obici L</author><journal>Arthritis Rheum</journal><year>2004</year><book /><volume>50</volume><number>9</number><pages>2966-2969</pages><co_aut>et al.</co_aut></literature><literature><id>1814</id><title>Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome</title><author>Takada K</author><journal>Arthritis Rheum</journal><year>2003</year><book /><volume>48</volume><number>9</number><pages>2645-2651</pages><co_aut>et al.</co_aut></literature><literature><id>1187</id><title>Increased urinary leukotriene E(4) during febrile attacks in the hyperimmunoglobulinaemia D and periodic fever syndrome</title><author>Frenkel J</author><journal>Arch Dis Child</journal><year>2001</year><book /><volume>85</volume><number>0</number><pages>185-189</pages><co_aut>et al.</co_aut></literature><literature><id>1188</id><title>Inherited disorders of cholesterol biosynthesis</title><author>Haas D</author><journal>Neuropediatrics</journal><year>2001</year><book /><volume>32</volume><number>0</number><pages>113-122</pages><co_aut>Kelley RI, Hoffmann GF</co_aut></literature><literature><id>1082</id><title>Mevalonic aciduria in 12 unrelated patients with hyperimmunglobulinaemia D and periodic fever syndrome</title><author>Poll-The BT</author><journal>J Inherit Metab Dis</journal><year>2000</year><book /><volume>23</volume><number>0</number><pages>363-366</pages><co_aut>et al.</co_aut></literature><literature><id>1083</id><title>[Identification of the gene for hyper-IgD syndrome: a model of modern genetics] [Article in Dutch]</title><author>Drenth JP</author><journal>Ned Tijdschr Geneeskd</journal><year>2000</year><book /><volume>144</volume><number>0</number><pages>782-785</pages><co_aut>et al.</co_aut></literature><literature><id>1084</id><title>Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome</title><author>Houten SM</author><journal>Nat Genet</journal><year>1999</year><book /><volume>22</volume><number>0</number><pages>175-177</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>